Breaking News Instant updates and real-time market news.

2021-02-22 16:27:49 OKE Oneok $46.19 / +0.35 (+0.76%) 16:27 02/22/21 02/22 16:27 02/22/21 16:27	Oneok sees FY21 diluted EPS midpoint of $2.74, consensus $3.03 Sees FY21 net income midpoint increase to $1.23B. Sees a 12% increase of adjusted EBITDA midpoint for FY21 to $3.05B. Sees a more than 70% decrease of total capital expenditures to a midpoint of $600M.	23 Feb 01 Mar 12 Jun
OKE Oneok $46.19 / +0.35 (+0.76%) 02/08/21 Fly Intel: Top five analyst downgrades 02/08/21 Seaport Global Oneok downgraded to Neutral at Seaport Global following 60% rally 02/08/21 Seaport Global Oneok downgraded to Neutral from Buy at Seaport Global 01/26/21 Citi Oneok price target raised to $41 from $32 at Citi

2021-02-22 16:27:49

OKE

Oneok

$46.19 / +0.35 (+0.76%)

16:27

02/22/21

02/22

16:27

02/22/21

16:27

Oneok sees FY21 diluted EPS midpoint of $2.74, consensus $3.03

Sees FY21 net income midpoint increase to $1.23B. Sees a 12% increase of adjusted EBITDA midpoint for FY21 to $3.05B. Sees a more than 70% decrease of total capital expenditures to a midpoint of $600M.

23
Feb
01
Mar

12
Jun

OKE Oneok

$46.19 / +0.35 (+0.76%)

02/08/21: Fly Intel: Top five analyst downgrades

02/08/21 Seaport Global: Oneok downgraded to Neutral at Seaport Global following 60% rally

02/08/21 Seaport Global: Oneok downgraded to Neutral from Buy at Seaport Global

01/26/21 Citi: Oneok price target raised to $41 from $32 at Citi

TODAY'S FREE FLY STORIES

Recommendations	Ambarella price target raised to $135 from $128 at Stifel » 07:12 03/03/21 03/03 07:12 03/03/21 07:12 AMBA Ambarella / + Stifel analyst Tore… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options AMBA Ambarella / + 03/02/21 Ambarella jumps 7% to $121.95 after Q4 results top estimates 03/02/21 Motional selects Ambarella CVflow AI processors for driverless vehicles 01/11/21 Ambarella unveils CV5 AI vision processor with 8K capabilities 12/28/20 FAA adopts final rules for drones 'advancing opportunities' for utilization AMBA Ambarella / + 02/24/21 Deutsche Bank Ambarella price target raised to $100 from $75 at Deutsche Bank 01/21/21 Stifel Ambarella price target raised to $118 from $110 at Stifel 01/13/21 Roth Capital Ambarella upgraded to Buy with $130 price target at Roth Capital 01/13/21 Roth Capital Ambarella upgraded to Buy from Neutral at Roth Capital AMBA Ambarella / + 03/02/21 Ambarella reports Q4 EPS 14c, consensus 8c 11/24/20 Ambarella sees Q4 revenue $56M-$60M, consensus $52.31M 11/23/20 Ambarella reports Q3 EPS 9c, consensus 5c AMBA Ambarella / + 03/02/21 Fly Intel: After-Hours Movers 12/14/20 Fly Insider: Molecular Templates, AMD among notable insider trades 12/07/20 Fly Insider: Foot Locker, Alexion among weeks notable insider trades 11/23/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference AMBA Ambarella / + 02/01/21 Ambarella call volume above normal and directionally bullish 01/21/21 Ambarella call volume above normal and directionally bullish 12/10/20 Ambarella call volume above normal and directionally bullish 12/03/20 Ambarella call volume above normal and directionally bullish
Recommendations	Quanterix price target raised to $90 from $86 at Canaccord » 07:12 03/03/21 03/03 07:12 03/03/21 07:12 QTRX Quanterix $77.06 / -5.61 (-6.79%) Canaccord analyst Max… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options QTRX Quanterix $77.06 / -5.61 (-6.79%) 02/12/21 Quanterix announces Simoa joint laboratory with WuXi AppTec 01/11/21 Quanterix gets FDA emergency use authorization for COVID protein antigen test 12/28/20 Quanterix gets FDA EUA for COVID antibody test with Simoa 12/24/20 Quanterix gets EUA for Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test QTRX Quanterix $77.06 / -5.61 (-6.79%) 01/27/21 SVB Leerink Quanterix price target raised to $75 from $50 at SVB Leerink 01/14/21 Canaccord Quanterix price target raised to $74 from $60 at Canaccord 01/12/21 Canaccord Quanterix price target raised to $60 from $54 at Canaccord 10/19/20 SVB Leerink Quanterix price target raised to $48 from $37 at SVB Leerink QTRX Quanterix $77.06 / -5.61 (-6.79%) 03/02/21 Quanterix reports Q4 loss from operations ($11.7M) vs. ($10.8M) last year 04 Feb 07 Aug QTRX Quanterix $77.06 / -5.61 (-6.79%) 03/02/21 Fly Intel: After-Hours Movers 01/11/21 Fly Intel: After-Hours Movers 03/02/21 41st Annual Healthcare Virtual Conference QTRX Quanterix $77.06 / -5.61 (-6.79%) 10/21/20 Eleven new option listings and one option delisting on October 21st
Hot Stocks	Charlotte's Web to enter U.S. cannabis wellness market » 07:12 03/03/21 03/03 07:12 03/03/21 07:12 CWBHF Charlotte's Web $0.00 / + (+0.00%) Charlotte's Web… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events CWBHF Charlotte's Web $0.00 / + (+0.00%) 02/26/21 Charlotte's Web announces scientific collaboration with McLean Hospital 01/12/21 Charlotte's Web announces two U.S. utility patents for hemp genetics CWBHF Charlotte's Web $0.00 / + (+0.00%) 09/15/20 Piper Sandler Charlotte's Web price target lowered to $4 from $7 at Piper Sandler 06/12/20 Cowen Charlotte's Web initiated with an Outperform at Cowen 03/23/20 Canaccord Charlotte's Web price target lowered to C$10 from C$17 at Canaccord 03/09/20 Cantor Fitzgerald Charlotte's Web price target lowered to $7 from $11.70 at Cantor Fitzgerald CWBHF Charlotte's Web $0.00 / + (+0.00%) 11/12/20 Rising High: Cannabis companies report earnings 03/25/21 Charlotte's Web - CWBHF
Downgrade	Singapore Airlines downgraded to Neutral from Overweight at JPMorgan » 07:12 03/03/21 03/03 07:12 03/03/21 07:12 SINGY Singapore Airlines $0.00 / + (+0.00%) JPMorgan analyst Karen Li… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SINGY Singapore Airlines $0.00 / + (+0.00%) 12/15/20 DBS Bank Singapore Airlines downgraded to Fully Valued from Hold at DBS Bank 11/10/20 JPMorgan Singapore Airlines upgraded to Overweight from Underweight at JPMorgan 11/09/20 Goldman Sachs Singapore Airlines upgraded to Neutral from Sell at Goldman Sachs 07/30/20 CIMB Singapore Airlines downgraded to Hold from Add at CIMB
Hot Stocks	Passage Bio announces anticipated upcoming milestones » 07:12 03/03/21 03/03 07:12 03/03/21 07:12 PASG Passage Bio $19.58 / + (+0.00%) Anticipated Upcoming… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options PASG Passage Bio $19.58 / + (+0.00%) 02/19/21 Passage Bio appoints Maxine Gowen to board of directors 02/08/21 Passage Bio's IND application for Krabbe disease candidate cleared by FDA 01/28/21 Passage Bio annoounces FDA IND clearance for PBFT02 01/11/21 Passage Bio says PBGM01 entering clinic to study safety, efficacy PASG Passage Bio $19.58 / + (+0.00%) 02/04/21 Fly Intel: Top five analyst initiations 02/04/21 Guggenheim Passage Bio initiated with a Buy at Guggenheim 01/25/21 Citi Citi upgrades Passage Bio to Buy after pullback and ahead of data 01/25/21 Citi Passage Bio upgraded to Buy from Neutral at Citi PASG Passage Bio $19.58 / + (+0.00%) 07:11 Today Passage Bio reports Q4 EPS (85c), consensus (70c) 11/10/20 Passage Bio reports Q3 EPS (63c), consensus (76c) 22 Jan PASG Passage Bio $19.58 / + (+0.00%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday 08:30 Today Passage Bio - PASG PASG Passage Bio $19.58 / + (+0.00%) 12/09/20 Nine new option listings on December 9th

Hot Stocks	Marker Therapeutics doses first patient in Phase 2 trial of MT-401 in AML » 07:12 03/03/21 03/03 07:12 03/03/21 07:12 MRKR Marker Therapeutics $2.50 / -0.04 (-1.57%) Marker Therapeutics has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MRKR Marker Therapeutics $2.50 / -0.04 (-1.57%) 01/05/21 Marker Therapeutics trading resumes 01/05/21 Marker Therapeutics: FDA lifts partial clinical hold on Phase 2 trial of MT-401 01/05/21 Marker Therapeutics trading halted, news pending MRKR Marker Therapeutics $2.50 / -0.04 (-1.57%) 01/05/21 Oppenheimer Marker hits 'important milestone' with end of clinical hold, says Oppenheimer 05/12/20 Fly Intel: Top five analyst downgrades 05/12/20 Piper Sandler Marker Therapeutics downgraded to Neutral from Overweight at Piper Sandler MRKR Marker Therapeutics $2.50 / -0.04 (-1.57%) 11/09/20 Marker Therapeutics reports Q3 EPS (16c), consensus (14c) 03/16/21 31st Annual Healthcare Virtual Conference
Earnings	Passage Bio reports Q4 EPS (85c), consensus (70c) » 07:11 03/03/21 03/03 07:11 03/03/21 07:11 PASG Passage Bio $19.58 / + (+0.00%) "At Passage Bio, we… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options PASG Passage Bio $19.58 / + (+0.00%) 02/19/21 Passage Bio appoints Maxine Gowen to board of directors 02/08/21 Passage Bio's IND application for Krabbe disease candidate cleared by FDA 01/28/21 Passage Bio annoounces FDA IND clearance for PBFT02 01/11/21 Passage Bio says PBGM01 entering clinic to study safety, efficacy PASG Passage Bio $19.58 / + (+0.00%) 02/04/21 Fly Intel: Top five analyst initiations 02/04/21 Guggenheim Passage Bio initiated with a Buy at Guggenheim 01/25/21 Citi Citi upgrades Passage Bio to Buy after pullback and ahead of data 01/25/21 Citi Passage Bio upgraded to Buy from Neutral at Citi PASG Passage Bio $19.58 / + (+0.00%) 11/10/20 Passage Bio reports Q3 EPS (63c), consensus (76c) 22 Jan PASG Passage Bio $19.58 / + (+0.00%) 01/22/21 Fly Intel: Wall Street's top stories for Friday 01/22/21 Fly Intel: Wall Street's top stories at midday 08:30 Today Passage Bio - PASG PASG Passage Bio $19.58 / + (+0.00%) 12/09/20 Nine new option listings on December 9th
Recommendations	Pulmonx price target raised to $65 from $49 at Canaccord » 07:11 03/03/21 03/03 07:11 03/03/21 07:11 LUNG Pulmonx $57.93 / -2.37 (-3.93%) Canaccord analyst William… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options LUNG Pulmonx $57.93 / -2.37 (-3.93%) 12/08/20 Pulmonx appoints Georgia Garinois-Melenikiotou, Thomas Burns to board 11/30/20 Pulmonx announces over 20,000 patient treated with non-surgical Zephyr Valve LUNG Pulmonx $57.93 / -2.37 (-3.93%) 01/04/21 BofA Pulmonx downgraded to Neutral from Buy at BofA 10/26/20 BofA Pulmonx initiated with a Buy at BofA 10/26/20 Canaccord Pulmonx initiated with a Buy at Canaccord 10/26/20 Morgan Stanley Pulmonx initiated with an Equal Weight at Morgan Stanley LUNG Pulmonx $57.93 / -2.37 (-3.93%) 03/02/21 Pulmonx reports Q4 EPS (27c), consensus (28c) 01 Oct LUNG Pulmonx $57.93 / -2.37 (-3.93%) 10/04/20 Opening Day: Palantir, Asana go public via direct listings LUNG Pulmonx $57.93 / -2.37 (-3.93%) 02/04/21 Six new option listings and one option delisting on February 4th
Earnings	Taysha Gene Therapies reports Q4 EPS (12c), consensus (37c) » 07:10 03/03/21 03/03 07:10 03/03/21 07:10 TSHA Taysha Gene Therapies $25.78 / -0.99 (-3.70%) Cash and cash… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events TSHA Taysha Gene Therapies $25.78 / -0.99 (-3.70%) 02/09/21 Taysha Gene Therapies announces multi-year collaborations for AAV gene therapies 01/26/21 Taysha Gene Therapies appoints Timothy Douros as CLO, Tracy Porter as CPO 01/19/21 Taysha gets both rare pediatric disease and orphan drug designations for TSHA-10 01/04/21 Taysha Gene Therapies announces multi-year collaboration with AllStripes TSHA Taysha Gene Therapies $25.78 / -0.99 (-3.70%) 02/23/21 William Blair William Blair starts Taysha with Outperform, $46 fair-value estimate 02/23/21 William Blair William Blair starts Taysha Gene Therapies with Outperform on positive FDA draft 02/23/21 William Blair Taysha Gene Therapies initiated with an Outperform at William Blair 01/04/21 Oppenheimer Taysha Gene Therapies initiated with an Outperform at Oppenheimer 24 Sep TSHA Taysha Gene Therapies $25.78 / -0.99 (-3.70%) 09/27/20 Opening Day: GoodRx rises over 50% in market debut 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever 03/16/21 31st Annual Healthcare Virtual Conference 08:00 Today Taysha Gene Therapies - TSHA
Hot Stocks	Carrols Restaurant targets 2021 net capital expenditures approx. $60M » 07:10 03/03/21 03/03 07:10 03/03/21 07:10 TAST Carrols Restaurant $6.55 / +0.16 (+2.50%) Daniel T. Accordino,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events TAST Carrols Restaurant $6.55 / +0.16 (+2.50%) 02/10/21 Carrols Restaurant appoints Jared Landaw as VP, general counsel 02/09/21 Carrols Restaurant appoints Carl Hauch as COO TAST Carrols Restaurant $6.55 / +0.16 (+2.50%) 01/15/21 BMO Capital Restaurant Brands price target raised to $70 from $65 at BMO Capital 01/15/21 Deutsche Bank Carrols Restaurant price target raised to $8 from $7 at Deutsche Bank 01/12/21 Baird Baird cautious Restaurant Brands ahead of results 11/09/20 Deutsche Bank Carrols Restaurant price target lowered to $7 from $8 at Deutsche Bank TAST Carrols Restaurant $6.55 / +0.16 (+2.50%) 07:08 Today Carrols Restaurant reports Q4 adjusted EPS 0c, consensus 2c 01/11/21 Carrols Restaurant sees 2020 revenue $1.55B, consensus $1.55B 01/11/21 Carrols Restaurant sees Q4 revenue $420.5M, consensus $421.47M 11/05/20 Carrols Restaurant reports Q3 EPS 9c, consensus 11c 08:30 Today Carrols Restaurant - TAST 03/26/21 Carrols Restaurant

Upgrade	Securitas upgraded to Outperform at Credit Suisse » 07:10 03/03/21 03/03 07:10 03/03/21 07:10 SCTBF Securitas $0.00 / + (+0.00%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SCTBF Securitas $0.00 / + (+0.00%) 05:15 Today Credit Suisse Securitas upgraded to Outperform from Underperform at Credit Suisse 02/11/21 RBC Capital Securitas price target lowered to SEK 110 from SEK 120 at RBC Capital 02/08/21 Deutsche Bank Securitas upgraded to Hold from Sell at Deutsche Bank 02/08/21 Pareto Securitas downgraded to Hold from Buy at Pareto
Hot Stocks	SPI Energy subsidiary enters supply contract with NSW AHO » 07:10 03/03/21 03/03 07:10 03/03/21 07:10 SPI SPI Energy $8.28 / -0.62 (-6.97%) SPI Energy announced its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Syndicate On The Fly Options SPI SPI Energy $8.28 / -0.62 (-6.97%) 01/27/21 SPI Energy receives board approval to spin off Phoenix Motorcars 01/25/21 SPI Energy commences construction on Hawaii solar carport project 01/21/21 SPI Energy subsidiary and Petersen-Dean sign agreement 01/19/21 SPI Energy subsidiary, Icona announce collaboration for all-electric vehicles 01 Oct SPI SPI Energy $8.28 / -0.62 (-6.97%) 01/12/21 Fly Intel: Pre-market Movers 10/27/20 Fly Intel: Pre-market Movers SPI SPI Energy $8.28 / -0.62 (-6.97%) 02/05/21 Largest borrow rate increases among liquid names 02/04/21 Largest borrow rate increases among liquid names 02/03/21 Largest borrow rate increases among liquid names 01/21/21 SPI Energy call volume above normal and directionally bullish
Downgrade	Saipem downgraded to Hold from Buy at Berenberg » 07:09 03/03/21 03/03 07:09 03/03/21 07:09 SAPMY Saipem $0.00 / + (+0.00%) Berenberg analyst Henry… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SAPMY Saipem $0.00 / + (+0.00%) 02/24/21 Perma-Pipe International announces contract award in excess of $5M SAPMY Saipem $0.00 / + (+0.00%) 02/26/21 Exane BNP Paribas Saipem downgraded to Underperform from Neutral at Exane BNP Paribas 01/26/21 Morgan Stanley Saipem price target raised to EUR 2.10 from EUR 1.90 at Morgan Stanley 01/06/21 JPMorgan Saipem price target raised to EUR 2.90 from EUR 2.50 at JPMorgan 11/20/20 JPMorgan Saipem price target lowered to EUR 2.50 from EUR 3.70 at JPMorgan
Recommendations	Urban Outfitters price target raised to $38 from $34 at Barclays » 07:09 03/03/21 03/03 07:09 03/03/21 07:09 URBN Urban Outfitters $33.75 / -0.4 (-1.17%) Barclays analyst Adrienne… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options URBN Urban Outfitters $33.75 / -0.4 (-1.17%) 01/12/21 Urban Outfitters drops 11% to $27.00 after posting holiday sales decline 12/03/20 Urban Outfitters appoints Melanie Marein-Efron as CFO 10/13/20 Urban Outfitters announces management changes URBN Urban Outfitters $33.75 / -0.4 (-1.17%) 02/26/21 Deutsche Bank Urban Outfitters named short-term investment idea at Deutsche Bank 02/10/21 RBC Capital Urban Outfitters price target raised to $30 from $28 at RBC Capital 01/21/21 Deutsche Bank Urban Outfitters price target raised to $32 from $31 at Deutsche Bank 01/14/21 Fly Intel: Top five analyst downgrades URBN Urban Outfitters $33.75 / -0.4 (-1.17%) 03/02/21 Urban Outfitters reports Q4 EPS 29c, consensus 28c 02/09/21 Urban Outfitters reports preliminary Q4 revenue $1.09B, consensus $1.1B 01/12/21 Urban Outfitters reports total net revenue for 2 months ended Dec 31 down 8.4% 01/12/21 Urban Outfitters reports total net revenue for 2 months ended Dec 31 down 8.4% URBN Urban Outfitters $33.75 / -0.4 (-1.17%) 03/02/21 Fly Intel: After-Hours Movers 02/26/21 Best Buy downgrade among today's top calls on Wall Street 02/09/21 Fly Intel: After-Hours Movers 01/13/21 Fly Intel: Pre-market Movers URBN Urban Outfitters $33.75 / -0.4 (-1.17%) 11/10/20 Early notable gainers among liquid option names on November 10th 09/14/20 Early notable gainers among liquid option names on September 14th
Hot Stocks	Wendy's says Q1 sales 'off to a strong start' » 07:09 03/03/21 03/03 07:09 03/03/21 07:09 WEN Wendy's $21.30 / +0.01 (+0.05%) Through the week ended… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's $21.30 / +0.01 (+0.05%) 07:08 Today Wendy's sees FY21 cash flows from operations: $310M-$330M 07:05 Today Wendy's reports Q4 global same-restaurant sales growth 4.7% 07:03 Today Wendy's reports Q4 U.S. systemwide sales growth of 14.2% 02/23/21 Wendy's raises quarterly dividend 29% to 9c per share WEN Wendy's $21.30 / +0.01 (+0.05%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank WEN Wendy's $21.30 / +0.01 (+0.05%) 07:07 Today Wendy's sees FY21 adjusted EPS 67c-69c, consensus 72c 07:00 Today Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's $21.30 / +0.01 (+0.05%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 08:30 Today Wendy's - WEN 03/16/21 Wendy's

Earnings	Carrols Restaurant reports Q4 adjusted EPS 0c, consensus 2c » 07:08 03/03/21 03/03 07:08 03/03/21 07:08 TAST Carrols Restaurant $6.55 / +0.16 (+2.50%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events TAST Carrols Restaurant $6.55 / +0.16 (+2.50%) 02/10/21 Carrols Restaurant appoints Jared Landaw as VP, general counsel 02/09/21 Carrols Restaurant appoints Carl Hauch as COO TAST Carrols Restaurant $6.55 / +0.16 (+2.50%) 01/15/21 BMO Capital Restaurant Brands price target raised to $70 from $65 at BMO Capital 01/15/21 Deutsche Bank Carrols Restaurant price target raised to $8 from $7 at Deutsche Bank 01/12/21 Baird Baird cautious Restaurant Brands ahead of results 11/09/20 Deutsche Bank Carrols Restaurant price target lowered to $7 from $8 at Deutsche Bank TAST Carrols Restaurant $6.55 / +0.16 (+2.50%) 01/11/21 Carrols Restaurant sees 2020 revenue $1.55B, consensus $1.55B 01/11/21 Carrols Restaurant sees Q4 revenue $420.5M, consensus $421.47M 11/05/20 Carrols Restaurant reports Q3 EPS 9c, consensus 11c 08:30 Today Carrols Restaurant - TAST 03/26/21 Carrols Restaurant
Hot Stocks	Broadridge granted patent for AI-driven digital trading protocol technology » 07:08 03/03/21 03/03 07:08 03/03/21 07:08 BR Broadridge $143.68 / -2.765 (-1.89%) Broadridge announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BR Broadridge $143.68 / -2.765 (-1.89%) 01/28/21 Broadridge begins development to be an approved SFT submitter 12/08/20 Broadridge selected by BEC for updated Shareholder Rights Directive 11/09/20 Broadridge names Edmund Reese as CFO, effective November 30 11/02/20 LiquidX announces multi-year investment from Broadridge BR Broadridge $143.68 / -2.765 (-1.89%) 02/03/21 BTIG Broadridge upgraded to Buy from Neutral at BTIG 12/18/20 Truist Broadridge initiated with a Buy at Truist 12/18/20 Truist Broadridge initiated with a Buy at Truist 08/17/20 JPMorgan Broadridge price target raised to $152 from $142 at JPMorgan BR Broadridge $143.68 / -2.765 (-1.89%) 02/02/21 Broadridge reports Q2 adjusted EPS 73c, consensus 70c 12/10/20 Broadridge backs FY21 adjusted EPS growth of 6%-10%, consensus $5.50 12/10/20 Broadridge targets adjusted EPS growth FY20-FY23 of 8%-12% 10/30/20 Broadridge reports Q1 adjusted EPS 98c, consensus 63c
Recommendations	Dine Brands price target raised to $95 from $80 at Barclays » 07:08 03/03/21 03/03 07:08 03/03/21 07:08 DIN Dine Brands $78.83 / -2.795 (-3.42%) Barclays analyst Jeffrey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings DIN Dine Brands $78.83 / -2.795 (-3.42%) 03/02/21 Dine Brands says Applebee's SSS improving roughly 8% QTD from January 03/02/21 Dine Brands sees FY21 capital expenditures $14M 11/17/20 Dine Brands names John Peyton, president and CEO DIN Dine Brands $78.83 / -2.795 (-3.42%) 02/10/21 Deutsche Bank Dine Brands downgraded to Hold from Buy at Deutsche Bank 01/20/21 Wedbush Dine Brands added to Best List Ideas, target raised to $83 at Wedbush 01/06/21 Raymond James Dine Brands upgraded to Outperform from Market Perform at Raymond James 01/06/21 Raymond James Dine Brands upgraded to Outperform from Market Perform at Raymond James DIN Dine Brands $78.83 / -2.795 (-3.42%) 03/02/21 Dine Brands reports Q4 adjusted EPS 39c, consensus 67c 10/28/20 Dine Brands reports Q3 EPS 80c, consensus 36c
Hot Stocks	Wendy's sees FY21 cash flows from operations: $310M-$330M » 07:08 03/03/21 03/03 07:08 03/03/21 07:08 WEN Wendy's $21.30 / +0.01 (+0.05%) Sees FY21 CapEx… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's $21.30 / +0.01 (+0.05%) 07:05 Today Wendy's reports Q4 global same-restaurant sales growth 4.7% 07:03 Today Wendy's reports Q4 U.S. systemwide sales growth of 14.2% 02/23/21 Wendy's raises quarterly dividend 29% to 9c per share 11/16/20 Peltz's Trian Fund exits BNY Mellon, cuts stake in GE in Q3 WEN Wendy's $21.30 / +0.01 (+0.05%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank WEN Wendy's $21.30 / +0.01 (+0.05%) 07:07 Today Wendy's sees FY21 adjusted EPS 67c-69c, consensus 72c 07:00 Today Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's $21.30 / +0.01 (+0.05%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 08:30 Today Wendy's - WEN 03/16/21 Wendy's
Recommendations	Ameresco price target raised to $82 from $52 at Canaccord » 07:08 03/03/21 03/03 07:08 03/03/21 07:08 AMRC Ameresco $56.53 / -3.925 (-6.49%) Canaccord analyst Jed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AMRC Ameresco $56.53 / -3.925 (-6.49%) 02/17/21 Ameresco in ESA pact with Nyack Public School District for phase ll renovations 02/05/21 Ameresco partners with Navy for $173M energy project at Norfolk Naval Shipyard 02/02/21 Ameresco, Wells Fargo announce collaboration to develop solar generation assets 11/25/20 Ameresco CEO sells 46.3K shares of common stock AMRC Ameresco $56.53 / -3.925 (-6.49%) 03/02/21 Oppenheimer Ameresco price target raised to $66 from $48 at Oppenheimer 02/09/21 B. Riley Securities Ameresco price target raised to $72 from $50 at B. Riley Securities 01/26/21 Craig-Hallum Ameresco price target raised to $75 from $50 at Craig-Hallum 11/03/20 Craig-Hallum Ameresco price target raised to $50 from $38 at Craig-Hallum AMRC Ameresco $56.53 / -3.925 (-6.49%) 03/01/21 Ameresco sees FY21 EPS $1.18-$1.26, consensus $1.22 03/01/21 Ameresco reports Q4 EPS 47c, consensus 29c 11/02/20 Ameresco raises FY20 adj. EPS view to 94c-$1.00 from 86c-96c 11/02/20 Ameresco reports Q3 adjusted EPS 38c, consensus 25c AMRC Ameresco $56.53 / -3.925 (-6.49%) 03/01/21 Fly Intel: After-Hours Movers 03/09/21 Sustainable Energy & Technology Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference

Hot Stocks	Exicure receives orphan drug designation for cavrotolimod from FDA » 07:07 03/03/21 03/03 07:07 03/03/21 07:07 XCUR Exicure $2.29 / +0.08 (+3.63%) Exicure announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly XCUR Exicure $2.29 / +0.08 (+3.63%) 03/02/21 Exicure's cavrotolimod granted FDA orphan status for merkel cell carcinoma 01/11/21 Exicure granted two FDA fast track designations for cavrotolimod 12/21/20 Exicure announces issuance of two new U.S. patents, and new patent allowance 12/21/20 Exicure announces issuance of two new U.S. patents, and new patent allowance XCUR Exicure $2.29 / +0.08 (+3.63%) 12/18/20 BMO Capital Exicure initiated with an Outperform at BMO Capital XCUR Exicure $2.29 / +0.08 (+3.63%) 11/12/20 Exicure reports Q3 EPS (3c), consensus (9c) XCUR Exicure $2.29 / +0.08 (+3.63%) 12/18/20 Fly Intel: Wall Street's top stories at midday 12/18/20 Fly Intel: Pre-market Movers
Earnings	Wendy's sees FY21 adjusted EPS 67c-69c, consensus 72c » 07:07 03/03/21 03/03 07:07 03/03/21 07:07 WEN Wendy's $21.30 / +0.01 (+0.05%) Sees FY21 Global… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events WEN Wendy's $21.30 / +0.01 (+0.05%) 07:05 Today Wendy's reports Q4 global same-restaurant sales growth 4.7% 07:03 Today Wendy's reports Q4 U.S. systemwide sales growth of 14.2% 02/23/21 Wendy's raises quarterly dividend 29% to 9c per share 11/16/20 Peltz's Trian Fund exits BNY Mellon, cuts stake in GE in Q3 WEN Wendy's $21.30 / +0.01 (+0.05%) 02/26/21 Stephens Wendy's named Best Idea at Stephens 01/27/21 Fly Intel: Top five analyst upgrades 01/27/21 Deutsche Bank Wendy's upgraded to Buy with $25 target at Deutsche Bank 01/27/21 Deutsche Bank Wendy's upgraded to Buy from Hold at Deutsche Bank WEN Wendy's $21.30 / +0.01 (+0.05%) 07:00 Today Wendy's reports Q4 adjusted EPS 17c, consensus 18c 11/04/20 Wendy's reports Q3 adjusted EPS 19c, consensus 17c 11/03/20 Notable companies reporting before tomorrow's open 11/03/20 Notable companies reporting before tomorrow's open WEN Wendy's $21.30 / +0.01 (+0.05%) 01/11/21 Zillow, Walgreens upgrades among today's top calls on Wall Street 01/07/21 Tesla upgrade, Coca-Cola downgrade among today's top calls on Wall Street 11/12/20 Home Depot upgrade, Lowe's downgrade among today's top calls on Wall Street 11/05/20 Microsoft, Verizon upgrades among today's top calls on Wall Street 08:30 Today Wendy's - WEN 03/16/21 Wendy's
Hot Stocks	Optinose expects topline results from OPN-019 study in 2Q21 » 07:06 03/03/21 03/03 07:06 03/03/21 07:06 OPTN Optinose $3.92 / -0.085 (-2.12%) In June 2020, the Company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events OPTN Optinose $3.92 / -0.085 (-2.12%) 07:05 Today Optinose expects topline results from one XHANCE trial by end of 2021 07:04 Today Optinose sees FY21 XHANCE revenues at least $80M 11/05/20 Optinose expects topline results from XHANCE trials in 2H21 09/29/20 Optinose announces peer-review publication on XHANCE data OPTN Optinose $3.92 / -0.085 (-2.12%) 06/30/20 Cantor Fitzgerald OptiNose anti-COVID-19 candidate could provide 'significant upside, says Cantor OPTN Optinose $3.92 / -0.085 (-2.12%) 07:05 Today Optinose expects Q1 XHANCE revenues to decrease vs. Q4 07:02 Today Optinose reports Q4 EPS (46c), consensus (46c) 11/05/20 Optinose reports Q3 EPS (43c), consensus (52c) 10/22/20 Optinose sees Q3 XHANCE net product revenues $15.4M 14 Aug 03/02/21 41st Annual Healthcare Virtual Conference 08:00 Today Optinose - OPTN
Downgrade	Pollard Banknote downgraded to Hold from Buy at Canaccord » 07:06 03/03/21 03/03 07:06 03/03/21 07:06 PBKOF Pollard Banknote $0.00 / + (+0.00%) Canaccord analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research PBKOF Pollard Banknote $0.00 / + (+0.00%) 02/09/21 Raymond James Pollard Banknote initiated with an Outperform at Raymond James 01/04/21 Canaccord Pollard Banknote price target raised to C$40 from C$25 at Canaccord 11/10/20 Canaccord Pollard Banknote price target raised to C$25 from C$21 at Canaccord 05/07/20 Canaccord Pollard Banknote price target raised to C$19 from C$18 at Canaccord
Hot Stocks	Emerson Electric announces first chief sustainability officer. Mike Train » 07:06 03/03/21 03/03 07:06 03/03/21 07:06 EMR Emerson Electric $87.61 / -0.82 (-0.93%) To enhance its focused… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals EMR Emerson Electric $87.61 / -0.82 (-0.93%) 02/25/21 Emerson Electric invests in Fluxa 02/17/21 Emerson Electric names Ram Krishnan COO 02/01/21 Emerson Electric CEO Farr to retire Lal Karsanbhai to succeed 12/17/20 Emerson Electric reports November trailing three-month orders down 4% EMR Emerson Electric $87.61 / -0.82 (-0.93%) 02/04/21 JPMorgan Emerson Electric price target raised to $95 from $85 at JPMorgan 02/03/21 Citi Emerson Electric price target raised to $98 from $94 at Citi 01/19/21 Goldman Sachs Emerson Electric upgraded to Buy from Neutral at Goldman Sachs 01/15/21 UBS Emerson Electric upgraded to Buy from Neutral at UBS EMR Emerson Electric $87.61 / -0.82 (-0.93%) 02/02/21 Emerson Electric sees FY21 EPS $3.70 +/- 10c consensus $3.51 02/02/21 Emerson Electric reports Q1 EPS 83c, consensus 69c 11/03/20 Emerson Electric sees FY21 adjusted EPS $3.45 +/- 5c, consensus $3.42 11/03/20 Emerson Electric reports Q4 adjusted EPS $1.10, consensus 94c EMR Emerson Electric $87.61 / -0.82 (-0.93%) 02/04/21 Emerson Electric considering sale of Appleton unit, Bloomberg says

Events

Earnings calls, analyst events, roadshows and more

OPTN
Today at 08:00

Optinose - OPTN Conference Calls
BQ
Today at 08:00

Boqii - BQ Conference Calls
ISEE
Today at 08:00

Iveric bio - ISEE Conference Calls
TSHA
Today at 08:00

Taysha Gene Therapies - TSHA Conference Calls
Today at 08:15

ADP Employment Report: Private Payrolls M/M: February 2021 Government Event
TAST
Today at 08:30

Carrols Restaurant - TAST Conference Calls
PASG
Today at 08:30

Passage Bio - PASG Conference Calls
CECE
Today at 08:30

CECO Environmental - CECE Conference Calls
SBBP
Today at 08:30

Strongbridge Biopharma - SBBP Conference Calls
WEN
Today at 08:30

Wendy's - WEN Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer $9.14 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares DGII X DGII Digi International Secondary Managers: Piper Sandler $23.46 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

Oneok sees FY21 diluted EPS midpoint of $2.74, consensus $3.03

TODAY'S FREE FLY STORIES

Get Full Fly Access